BioCentury
DATA GRAPHICS | Product Development

Gene therapy’s next class of biotechs

And the innovative technologies they’re developing

October 23, 2021 2:30 AM UTC

It’s been a rough year for gene therapies in the clinic, but that hasn’t slowed momentum for the new class of biotechs working on next-generation technology for the modality’s challenges. 

BioCentury’s analysis of 51 gene therapy companies founded within the past five years exposes an approaching shift in the technology landscape. ...